Show simple item record

dc.contributor.authorBlanks, Jes_ES
dc.contributor.authorRichards, Fes_ES
dc.contributor.authorBeltrán, Fes_ES
dc.contributor.authorCollins, Res_ES
dc.contributor.authorAlvarez, Ees_ES
dc.contributor.authorZea Flores, Ges_ES
dc.contributor.authorBauler, Bes_ES
dc.contributor.authorCedillos, Res_ES
dc.contributor.authorHeisler, Mes_ES
dc.contributor.authorBrandling-Bennett, Des_ES
dc.contributor.authorBaldwin, Wes_ES
dc.contributor.authorBayona, Mes_ES
dc.contributor.authorKlein, Res_ES
dc.contributor.authorJacox, Mes_ES
dc.date.accessioned2015
dc.date.available2015
dc.date.issued1998es_ES
dc.identifier.citationBlanks, J,Richards, F,Beltrán, F,Collins, R,Alvarez, E,Zea Flores, G,Bauler, B,Cedillos, R,Heisler, M,Brandling-Bennett, D,Baldwin, W,Bayona, M,Klein, R,Jacox, M (1998) The onchocerciasis elimination program for the Americas: a history of partnership. Rev Panam Salud Publica;3(6) -,jun. 1998. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998000600002&lng=pt&nrm=isoes_ES
dc.identifier.urihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998000600002&lng=pt&nrm=isoes_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/8975
dc.format.extenttabes_ES
dc.relation.ispartofseriesRev Panam Salud Publica;3(6),jun. 1998es_ES
dc.subjectOncocercosees_ES
dc.subjectIvermectinaes_ES
dc.subjectPopulação Ruralpt_BR
dc.subjectCooperação Técnicapt_BR
dc.subjectCooperação Econômicapt_BR
dc.subjectPolítica de Saúdept_BR
dc.subjectAmérica Latinaes_ES
dc.titleThe onchocerciasis elimination program for the Americas: a history of partnershipes_ES
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US
dc.description.notesThe decision in 1987 by the pharmaceutical firm Merck & Co. to provide Mectizan (ivermectin) free of charge to river blindness control programs has challenged the international public health community to find effective ways to distribute the drug to rural populations most affected by onchocerciasis. In the Americas, PAHO responded to that challenge by calling for the elimination of all morbidity from onchocerciasis from the Region by the year 2007 through mass distribution of ivermectin. Since 1991, a multinational, multiagency partnership (consisting of PAHO, the endemic countries, nongovernmental development organizations, the Centers for Disease Control and Prevention in Atlanta, Georgia, as well as academic institutions and funding agencies) has developed the political, financial, and technical support needed to move toward the realization of that goal. This partnership is embodied in the Onchocerciasis Elimination Program for the Americas (OEPA), which is supported by the River Blindness Foundation (RBF) and now by the Carter Center. OEPA was conceived as a means of maintaining a regional initiative to eliminate what is otherwise a low priority disease. Since its inception in 1993, the OEPA has provided more than US$2 million in financial, managerial, and technical assistance to stimulate and/or support programs in Brazil, Colombia, Ecuador, Guatemala, Mexico and Venezuela, so as to take full advantage of the Merck donation. Now halfway into a five-year, US$ 4 million grant provided through the Inter-American Development Bank, the OEPA's capacity to support the regional initiative is assured through 1999en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record